Skip navigation

Refine by Type

Results 1 - 10 of 23 for ALEMTUZUMAB
  1. Alemtuzumab injection is used to treat B-cell chronic lymphocytic leukemia (a slowly developing cancer in which ... of white blood cell accumulate in the body). Alemtuzumab is in a class of medications called monoclonal ...
  2. ... gotten better after treatment with fludarabine (Fludara) and alemtuzumab (Campath). Ofatumumab injection is in a class of ...
  3. ... to treat mycosis fungoides and the Sézary syndrome. Alemtuzumab and denileukin diftitox are monoclonal antibodies used to ... with pralatrexate . Targeted therapy with a monoclonal antibody ( alemtuzumab or denileukin diftitox ). A clinical trial of ultraviolet ...
  4. ... or ofatumumab PCR: pentostatin (Nipent), cyclophosphamide, and rituximab Alemtuzumab (Campath) Fludarabine (alone) Other drugs or combinations of ... For many people who have already had fludarabine, alemtuzumab seems to be helpful as second-line treatment, ...
  5. Index to Drug-Specific Information (Food and Drug Administration)  
    ... fluticasone propionate; salmeterol xinafoate) Adderall (amphetamine salts) Alendronate Alemtuzumab Aleve (naproxen sodium) Alimta (pemetrexed) Aliskiren Alli (orlistat) ...
  6. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Fluorouracil) Afatinib Dimaleate Afinitor (Everolimus) Aldara (Imiquimod) Aldesleukin Alemtuzumab Alimta (Pemetrexed Disodium) Aloxi (Palonosetron Hydrochloride) Ambochlorin (Chlorambucil) ...
  7. Travelers' Health: Immunocompromised Travelers (Centers for Disease Control and Prevention)  
    ... 4 Adalimumab Humira TNF blocker Alefacept Amevive CD2 Alemtuzumab Campath Anti-CD52 Anakinra Kineret IL-1 Basiliximab ... other TNF blockers. Lymphocyte-depleting agents such as alemtuzumab and rituximab may cause prolonged immunosuppression. Restarting immunosuppression ...
  8. Drugs Approved for Leukemia From the National Institutes of Health (National Cancer Institute)  
    ... Top Drugs Approved for Chronic Lymphocytic Leukemia (CLL) Alemtuzumab Ambochlorin (Chlorambucil) Amboclorin (Chlorambucil) Arzerra (Ofatumumab) Bendamustine Hydrochloride ...
  9. Peripheral T-Cell Lymphoma (Lymphoma Research Foundation) - PDF  
    ... clinical trials for the treatment of PTCL, including: • Alemtuzumab (Campath) • Alisertib (MLN8237) • Bortezomib (Velcade) • Brentuximab Vedotin (Adcetris) • ...
  10. Pancreatic Islet Transplantation From the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)  
    ... used in islet transplantation include antithymocyte globulin (Thymoglobulin), alemtuzumab (Campath), basiliximab (Simulect), belatacept (Nulojix), etanercept (Enbrel), everolimus ( ...
previous · 1 · 2 · 3 · next